Blue Chip Partners, LLC’s Abbott Laboratories Position
Does Blue Chip Partners, LLC own Abbott Laboratories (ABT)? Yes — 208.7K shares worth $21M (+1.54% of its 13F portfolio) as of Q1 2026, up from 206.4K shares the prior filed quarter.
Position Value
$21M
Q1 2026
Shares
208.7K
% of Portfolio
+1.54%
Quarters Held
30
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 208.7K | $21M | +1.54% |
| Q4 2025 | 206.4K | $26M | +1.88% |
| Q3 2025 | 201.9K | $27M | +2.02% |
| Q2 2025 | 194.7K | $26M | +2.16% |
| Q1 2025 | 191.0K | $25M | +2.19% |
| Q4 2024 | 179.5K | $20M | +1.75% |
| Q3 2024 | 178.1K | $20M | +1.76% |
| Q2 2024 | 172.7K | $18M | +1.66% |
| Q1 2024 | 161.9K | $18M | +1.79% |
| Q4 2023 | 145.4K | $16M | +1.67% |
| Q3 2023 | 152.1K | $15M | +1.76% |
| Q2 2023 | 148.9K | $16M | +1.84% |
| Q1 2023 | 143.9K | $15M | +1.73% |
| Q4 2022 | 135.9K | $15M | +1.86% |
| Q3 2022 | 108.6K | $11M | +1.44% |
| Q2 2022 | 108.2K | $12M | +1.50% |
| Q1 2022 | 102.7K | $12M | +1.51% |
| Q4 2021 | 92.2K | $13M | +1.63% |
| Q3 2021 | 82.0K | $10M | +1.36% |
| Q2 2021 | 31.2K | $4M | +0.52% |
| Q1 2021 | 31.2K | $4M | +0.57% |
| Q4 2020 | 31.8K | $3M | +0.54% |
| Q3 2020 | 31.5K | $3M | +0.61% |
| Q2 2020 | 31.4K | $3M | +0.56% |
| Q1 2020 | 31.4K | $2M | +0.62% |
| Q4 2019 | 36.2K | $3M | +0.60% |
| Q3 2019 | 36.4K | $3M | +0.64% |
| Q2 2019 | 36.5K | $3M | +0.69% |
| Q1 2019 | 36.5K | $3M | +0.69% |
| Q4 2018 | 37.2K | $3M | +0.68% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Blue Chip Partners, LLC’s full portfolio or all institutional holders of ABT.